ANIMAL BLOOD PRODUCT MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2025 - 2032)

Global Animal Blood Products Market Size and Forecast – 2025 to 2032

The Global Animal Blood Products Market is estimated to be valued at USD 4.76 Bn in 2025 and is expected to reach USD 7.74 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 7.2% from 2025 to 2032.

Key Takeaways of the Global Animal Blood Products Market:

• In 2025, whole blood is expected to account for the largest share of the market by product type, contributing 23.6%, driven by its broad range of applications and vital role in both veterinary care and research environments.
• By end user, pharmaceutical companies is expected to hold the dominant position with a 30.1% market share in 2025, attributed to their robust R&D initiatives that extensively utilize animal blood products.
• On the basis of source animal, bovine is expected to lead the global animal blood products market with a 23.2% share in 2025, owing to the widespread availability of cattle and the high quality of blood components derived from them.
• North America is expected to lead the market, holding a share of 38.3% in 2025. Asia Pacific is anticipated to be the fastest-growing region, with a market share of 30.2% in 2025.

Market Overview:

The animal blood products market is experiencing significant growth due to increasing demand for animal-derived products in various applications such as animal feed, pharmaceuticals, and diagnostics. The rising prevalence of zoonotic diseases and the growing emphasis on animal health and welfare are driving the demand for animal blood products. Additionally, advancements in blood collection and processing technologies, along with the expansion of animal healthcare infrastructure, are expected to further propel market growth during the forecast period.

Currents Events and their Impact

Uncover macros and micros vetted on 75+ parameters: Get instant access to report

Segmental Analysis

To learn more about this report, Download Free Sample

Animal Blood Products Market Insights, By Product Type - Whole Blood Dominates Due to Its Critical Role in Veterinary Transfusions

In terms of product type, the whole blood segment is expected to contribute the highest share of the market with 23.6% in 2025 owing to its versatile applications and critical role in various veterinary and research settings. Whole blood, which contains all the essential components such as red blood cells, white blood cells, platelets, and plasma, is a key driver of growth in this segment.

One of the primary factors propelling the demand for whole blood is its use in life-saving transfusions for animals suffering from severe blood loss due to accidents, surgeries, or illnesses. Veterinary clinics and emergency centers rely heavily on the availability of whole blood products to treat critically ill or injured animals, ensuring their recovery and survival.

Animal Blood Products Market Insights, By End User - Pharmaceutical Companies Lead Market Share Owing to Extensive R&D Demand

In terms of end user, the pharmaceutical companies segment is expected to contribute the highest share of the animal blood products market with a share of 30.1% in 2025 due to their extensive research and development activities involving animal blood products. These companies rely heavily on animal-derived blood components to advance their drug discovery and testing processes.

One of the primary factors driving the demand for animal blood products in pharmaceutical companies is the need for preclinical testing of new drugs and therapies. Before any potential treatment can be tested on humans, it must undergo rigorous safety and efficacy assessments in animal models. Animal blood products, such as serum and plasma, are essential for in vitro studies, toxicology evaluations, and pharmacokinetic analyses. Pharmaceutical companies require a consistent and reliable supply of these products to conduct their research effectively.

Animal Blood Products Market Insights, By Source Animal - Bovine Remains the Preferred Source Due to Abundant Supply and Versatile Applications

Bovine is the leading source animal in the global animal blood products market with an estimated share of 23.2% in 2025, primarily due to the high availability of cattle and the superior quality of blood components derived from them. Bovine serum albumin (BSA) is widely used in pharmaceutical research, cell culture, and diagnostic applications owing to its stability, purity, and compatibility. These products are also essential in veterinary medicine for vaccine production and disease diagnostics, especially for livestock and zoonotic conditions.

In addition, bovine blood components like hemoglobin and plasma proteins find applications in the food and nutraceutical industries as natural sources of iron and functional ingredients. Countries with large bovine populations, such as the U.S., Brazil, and India, support a consistent supply chain, while established regulatory frameworks further boost market acceptance. These factors make bovine the most commercially viable and preferred source in the animal blood products industry.

Regional Insights

To learn more about this report, Download Free Sample

North America Animal Blood Products Market Analysis and Trends

In North America, the dominance in the global animal blood products market with an estimated share of 38.3% in 2025 can be attributed to several factors. The region boasts a well-established and advanced veterinary healthcare infrastructure, coupled with a high demand for companion animal care. The presence of major players in the animal health industry, such as Zoetis and Elanco, further strengthens the market ecosystem. Additionally, favorable government regulations and a strong emphasis on animal welfare contribute to the market's growth. The U.S., in particular, leads the region, driven by a large pet population and substantial investments in research and development. For instance, Zoetis is a leading U.S.-based animal health company known for its wide portfolio of medicines, vaccines, and diagnostic products. Zoetis has advanced its focus on biological research and plasma-based therapies through collaborations with veterinary clinics and research institutions across the U.S.

Asia Pacific Animal Blood Products Market Analysis and Trends

Meanwhile, the Asia Pacific region is expected to exhibit the fastest growth in the global animal blood products market with a share of 30.2% in 2025. The region's rapid economic development, increasing pet ownership, and rising awareness about animal health are key drivers of this growth. Countries like China and India are witnessing a surge in the demand for animal blood products, fueled by the expansion of the livestock industry and the growing emphasis on food safety. Moreover, government initiatives to promote animal health and prevent zoonotic diseases are creating a conducive environment for market growth. Japan and Australia are also notable contributors, with advanced veterinary healthcare systems and a strong focus on pet care. The presence of local players and increasing collaborations with global companies are further propelling the market's growth in the Asia Pacific region.

Global Animal Blood Products Market Outlook for Key Countries

U.S. Animal Blood Products Market Trends

The U.S. market for animal blood products is highly developed and mature. The country's large pet population, coupled with advanced veterinary healthcare facilities, drives the demand for these products. Major players like Zoetis and Elanco have a strong presence in the U.S., continuously introducing innovative products and technologies. The market is also influenced by stringent regulations set by the United States Department of Agriculture (USDA) and the U.S. Food and Drug Administration (FDA), ensuring the safety and quality of animal blood products.

 For instance, in June 2023, Proliant Health & Biologicals, a prominent U.S.-based manufacturer known for its high-quality Bovine Serum Albumin (BSA), entered into a strategic partnership with LAMPIRE Biological Laboratories, a key provider of biological reagents and custom antibody production. The collaboration aims to expand the distribution of bovine derivatives and related products to smaller-scale customers in the life sciences sector.

Belgium Animal Blood Products Market Trends

The Belgium animal blood products market is undergoing notable transformations, driven by advancements in biotechnology and a growing emphasis on sustainability. Innovative initiatives, such as the Belgian Red Cross-Flanders' development of an animal-friendly method to produce serum from expired human platelets, exemplify the country's commitment to ethical and sustainable practices in biotechnology.

For instance, in November 2024, VEOS Group, a global provider of sustainable, high-quality protein solutions for the food and animal feed sectors, headquartered at Belgium, has acquired the operations of OvaInnovations, a U.S.-based producer of inedible egg proteins. This strategic acquisition enhances VEOS Group’s footprint in the Belgium animal blood products market and supports its commitment to circular and eco-friendly production practices, strengthening its global supply capabilities and customer responsiveness.

U.K. Animal Blood Products Market Trends

The U.K. animal blood products market is experiencing significant growth, propelled by advancements in biotechnology and increasing demand across various sectors. Key drivers include the rising need for high-quality animal feed, expanding applications in the pharmaceutical and food industries, and technological innovations in plasma processing. These developments are enhancing the quality and safety of animal blood products, making them more appealing for use in pet food, cell culture media, and sports nutrition. However, the market faces challenges such as stringent regulatory frameworks and ethical concerns regarding animal welfare, which could impact the pace of growth.

For instance, Pet Blood Bank UK introduced a new offering—Canine Platelet Concentrate—providing veterinarians with faster and more convenient access to this critical blood product. The launch underscores the organization’s ongoing commitment to supporting the veterinary community with timely and life-saving resources.

China Animal Blood Products Market Trends

In China, the animal blood products market is growing steadily, supported by increasing demand from the pharmaceutical and animal feed industries. Companies like Wuhan Zhongyuan Animal Biotech Co., Ltd. are leading the domestic market with their production of animal serum and plasma used in veterinary medicine and research. Additionally, international firms such as VEOS Group have expanded their presence in China to provide sustainable protein and blood-derived solutions. Government efforts to enforce biosafety regulations in animal by-product processing are also contributing to improved standards and market stability.

End User Feedback and Unmet Needs

• End users of animal blood products across pharmaceutical, veterinary, and diagnostic sectors have expressed both appreciation and concerns regarding current market offerings. A notable positive example comes from veterinary research institutions, which frequently highlight the reliability and high bioactivity of bovine-derived serum used in cell culture applications. Users report consistent performance in immunological assays and vaccine development, attributing value to the product's quality assurance and standardized processing. This has translated into streamlined research workflows and improved experimental reproducibility, reinforcing user trust in established suppliers.
• Conversely, a common concern raised by biopharmaceutical manufacturers and smaller diagnostic labs revolves around product accessibility and batch variability. End users cite challenges related to global supply chain inconsistencies, high procurement costs, and limited availability of species-specific or pathogen-free blood derivatives. Additionally, many users seek enhanced integration with automated lab systems, yet current formats lack the necessary adaptability. These pain points point to critical unmet needs—including demand for affordable, scalable, and customizable solutions with better documentation and traceability. Addressing these gaps presents a significant opportunity for manufacturers to differentiate offerings, strengthen client relationships, and foster innovation through targeted R&D investments and collaborative end user engagement.

Market Players, Key Developments, and Competitive Intelligence

To learn more about this report, Download Free Sample

Key Developments:

• In July 2024, the KU Center for Animal Blood Medical Science at Konkuk University, South Korea, has successfully introduced Asia’s first canine mobile blood donation unit—an innovative step to enhance accessibility and awareness around veterinary blood donation. The customized vehicle, equipped with lab and collection facilities, enabled nationwide dog participation through a well-promoted campaign.
• In November 2024, the Royal Veterinary College (RVC), one of the U.K.’s leading veterinary institutions, is celebrating 20 years of its Blood Donor Programme with the launch of a new Transfusion Medicine Centre at its U.K. campus.
• In August 2023, UAnimals, a Ukrainian animal welfare organization known for its initiatives to protect and save animals, launched a new digital platform to facilitate animal blood donations. The platform connects pet owners willing to register their animals as donors with those in urgent need of blood transfusions—often critical after accidents, poisoning, or illness. The site provides clear medical guidelines to ensure donor safety and outlines required health checks.

Top Strategies Followed by Global Animal Blood Products Market Players

• Established players in the global animal blood products market are focusing on extensive research and development to innovate high-performance products. These companies invest heavily in R&D to develop advanced solutions that cater to the evolving needs of the market. For instance, leading firms are working on developing novel blood collection and processing techniques to enhance the quality and safety of animal blood products.
  • For example, the Canadian Animal Blood Bank (CABB) is emerging as a national leader in animal blood banking, known for its rigorous donation testing, rotating donor base, and expert quality control. With a mission to deliver high-quality blood products quickly and efficiently, CABB is setting a new benchmark in an industry that currently lacks standardized protocols for canine transfusions—raising the bar for veterinary care across Canada.

• Mid-level players in the animal blood products market are adopting strategies focused on delivering cost-effective solutions to target price-sensitive consumers. These companies are investing in research and development to create quality products that are affordable and accessible to a wider range of customers.
  • For example, Neogen, a food safety company, focuses on extensive R&D to innovate high-performance animal blood products. They have developed advanced blood collection techniques, enhancing both quality and safety.

• Small-scale players in the animal blood products market are targeting niche markets with unique features or innovative products. These companies are focusing on developing specialized solutions that cater to specific market segments or customer needs. By carving out a niche, small-scale players can differentiate themselves from larger competitors and attract customers looking for tailored solutions.
  • For example, Hemostat Laboratories and TCS Biosciences, provide targeted solutions. Hemostat specializes in animal blood products specifically tailored for microbiology media preparation, targeting smaller laboratories with precise needs. TCS Biosciences, based in the U.K., offers specialized blood and sera products for in-vitro diagnostics and continues to invest in advanced production techniques to improve quality and reliability.

Market Report Scope

Animal Blood Products Market Dynamics

To learn more about this report, Download Free Sample

Animal Blood Products Market Driver - Rising demand for animal-derived products in pharmaceuticals and diagnostics

The global animal blood products market is experiencing significant growth due to the increasing demand for animal-derived products in the pharmaceutical and diagnostic industries. Animal blood products, such as serum, plasma, and albumin, play a crucial role in the production of various medications, vaccines, and diagnostic reagents. These products are essential for research and development, as well as for the manufacture of life-saving treatments. The pharmaceutical industry heavily relies on animal blood products for the production of biologics, which are drugs derived from living organisms. The rising prevalence of chronic diseases and the growing need for innovative treatments are driving the demand for biologics, thereby boosting the demand for animal blood products. Furthermore, the diagnostic industry utilizes animal blood products in the development of assays and reagents used for disease detection and monitoring. As the focus on early disease diagnosis and personalized medicine continues to grow, the demand for animal blood products in the diagnostic sector is expected to rise accordingly. For example, Thermo Fisher Scientific, a global leader in scientific instrumentation and life sciences, supplies a wide range of animal-derived blood products such as fetal bovine serum (FBS), porcine serum, and bovine plasma. These products are used extensively in cell culture, biopharmaceutical development, and diagnostic reagent manufacturing.

Animal Blood Products Market Opportunity - Emerging Applications in Cell Culture Media and Regenerative Medicine

The global animal blood products market is witnessing a promising opportunity in the form of emerging applications in cell culture media and regenerative medicine. Animal blood products, such as fetal bovine serum (FBS), have long been used as a crucial component in cell culture media for various research and development purposes. However, the increasing demand for advanced cell culture techniques, such as 3D cell culture and organoid development, has opened up new avenues for animal blood products. These products play a vital role in providing the necessary growth factors, nutrients, and other essential components required for the successful cultivation and maintenance of cells in these complex systems.

For instance, platelet-rich plasma (PRP) derived from animal blood is being explored for its potential in promoting tissue regeneration, wound healing, and the treatment of various musculoskeletal disorders. The unique properties of animal blood products, such as their ability to stimulate cell proliferation and differentiation, make them valuable tools in the development of innovative regenerative therapies. For example, RegenLab, a leader in autologous PRP technology, has extended its platelet-rich plasma (PRP) kits for veterinary use, sourcing components from animal blood.

Analyst Opinion (Expert Opinion)

• The global animal blood products market is witnessing steady growth driven by advancements in biotechnological processing, increased use in diagnostics, pharmaceuticals, and veterinary care, and expanding research in life sciences. Regulatory support for animal-derived ingredients in vaccine development and rising demand from industries such as cell culture and microbiology are further fueling market expansion. However, the market also faces notable challenges, including ethical concerns regarding animal-derived products, stringent quality control regulations, and limited standardized protocols across regions. Emerging opportunities lie in expanding applications in regenerative medicine, the growing demand for cost-effective substitutes in diagnostics, and increasing collaborations between veterinary institutes and biopharma companies.
• In recent years, several conferences have played a critical role in shaping the animal blood products ecosystem. Events such as EuroTier (Germany), World Veterinary Congress, and Animal Health Innovation Europe have facilitated knowledge-sharing on blood-derived biotechnologies, veterinary transfusion standards, and supply chain challenges. Real-world examples include the Canadian Animal Blood Bank’s advanced donor screening protocols, and Thermo Fisher Scientific’s expansion in serum and blood-based reagents. Additionally, pilot programs in Asia-Pacific to establish national veterinary blood banks and government-backed biopharma partnerships in Europe are expected to positively impact availability, traceability, and safety in animal blood sourcing.

Market Segmentation

•  Product Type Insights (Revenue, USD Bn, 2020 - 2032)
• • Whole Blood
  • Plasma
  • Serum
  • Red Blood Cells
  • Platelets
  • White Blood Cells
  • Other Blood Derivatives (e.g., immunoglobulins, fibrinogen, serum albumin)
•  End User Insights (Revenue, USD Bn, 2020 - 2032)
• • Pharmaceutical Companies
  • Academic and Research Institutes
  • Veterinary Clinics
  • Diagnostic Laboratories
  • Blood Transfusion Services
  • Others (Academic and Research Institutions)
•  Source Animal Insights (Revenue, USD Bn, 2020 - 2032)
• • Bovine
  • Porcine
  • Equine
  • Canine
  • Feline
  • Others
•  Distribution Channel Insights (Revenue, USD Bn, 2020 - 2032)
• • Online
  • Offline
• Regional Insights (Revenue, USD Bn, 2020 - 2032)
• • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • North Africa
    • Central Africa
• Key Players Insights
• • Neogen Corporation
  • VetBiotek
  • Hemostatix
  • BioProducts Laboratory Ltd
  • Vetoquinol
  • Grifols S.A.
  • Luitpold Pharmaceuticals
  • Zoetis Inc.
  • IDEXX Laboratories Inc.
  • Parnell Pharmaceuticals
  • Elanco Animal Health
  • Merck Animal Health
  • Cegelec
  • Virbac
  • Pfizer Animal Health

Sources

Primary Research Interviews:

• Veterinarians and Veterinary Pathologists
• Biotechnologists and Hematology Researchers
• Procurement Managers in Pharmaceutical & Biotech Firms
• Academic Experts in Animal Health and Biomedical Sciences
• Product Managers from Diagnostic and Research Labs

Databases:

• U.S. Food and Drug Administration (FDA)
• European Medicines Agency (EMA)
• United States Department of Agriculture (USDA)
• Animal and Plant Health Inspection Service (APHIS)
• Centers for Disease Control and Prevention (CDC)
• World Organisation for Animal Health (WOAH/OIE)

Magazines:

• Animal Pharm
• Veterinary Practice News
• Genetic Engineering & Biotechnology News (GEN)
• BioTechniques
• Pharmaceutical Technology
• Lab Animal Magazine

Journals:

• Journal of Veterinary Science
• Transfusion
• Veterinary Clinical Pathology
• BMC Veterinary Research
• Theriogenology
• Journal of Animal Science

Newspapers:

• The New York Times – Science Section
• The Guardian – Health & Science
• The Washington Post – Health
• BBC News – Science & Environment
• Reuters Health

Associations:

• American Veterinary Medical Association (AVMA) – www.avma.org
• European Society of Veterinary Clinical Pathology (ESVCP) – www.esvcp.org
• International Society for Animal Genetics (ISAG) – www.isag.us
• International Society for Transfusion Medicine

Public Domain Sources:

• Directory of Open Access Journals (DOAJ)
• UN Comtrade Database
• World Bank Open Data
• FAO Statistical Databases (FAOSTAT)
• OECD iLibrary – Veterinary and Agriculture Statistics

Proprietary Elements:

• CMI Data Analytics Tool: Proprietary analytics tool to analyze real-time market trends, consumer behavior, and technology adoption in market
• Proprietary CMI Existing Repository of Information for Last 8 Years